📢 Spread the word! The 2024 Symposium Travel Awards Program is here to support YOU!

Whether you're a student, patient, caregiver, or part of an equity-deserving group, we want you to be part of the #CADTHSymp on Sept 4-6.

Apply before April 19 at cadth.ca/2024-symposium…

Fantastic opening discussion at #ChoosingWisely2024 w/ experts on medication appropriateness in 🇨🇦 focusing on current challenges & future opportunities in hospital, primary & long-term care

Barbara Farrell, Emily McDonald, Dr. John Hirdes & moderated by Sudha Kutty CADTH

Catching up with old friends at the Choosing Wisely 10th Anniversary Conference. I can proudly say we were all there at the beginning of CWC and have watched it grow over the years. Congratulations to Tai Huynh and Dr Wendy Levinson and the whole CWC team #ChoosingWisely2024

CADTH and @ChoosingWiselyCA hosted a multidisciplinary panel of experts to provide guidance on the minimum retesting intervals for 7 commonly used lab tests. We are seeking feedback on the draft recommendations.

Deadline is April 26, 2024.
cadth.ca/minimum-retest…

#HTA

Elizabeth Carson speaks at #ChoosingWisely2024 about our collaboration with ChoosingWiselyCanada to develop guidance on minimum retesting intervals for lab tests.

Learn more 👉 cadth.ca/minimum-retest…

#HTA #CdnHealth

⚠️Call for Patient and Clinician Input⚠️ CADTH is requesting input on leniolisib for activated phosphoinositide 3-kinase delta syndrome (APDS).

Deadline is April 30, 2024: cadth.ca/leniolisib #HTA

⚠️Call for Patient and Clinician Input⚠️ CADTH is requesting input on sotatercept for pulmonary arterial hypertension (WHO group 1).

Deadline is April 22, 2024: cadth.ca/sotatercept #HTA

🌟 2024 Recognition Awards Now Accepting Nominations  🌟

Nominations are now being accepted for 4 awards for outstanding achievement in the field of health technology assessment ( #HTA ) in Canada. 

Learn more and submit a nomination before May 10: cadth.ca/2024-symposium…

⚠️Call for Patient and Clinician Input⚠️ CADTH is requesting input on eplontersen for polyneuropathy in hereditary transthyretin-mediated amyloidosis (hATTR).

Deadline is April 22, 2024: cadth.ca/eplontersen #HTA

⌛ Time is running out to apply for the 2024 Symposium Travel Awards Program!

This program supports attendance for individuals who could not participate in the Symposium without financial support.

Learn more about eligibility and submit by April 19: cadth.ca/2024-symposium…

Our new interactive Pharmaceutical Data Tool simplifies information about public drug programs. Explore the design and coverage of Canadian public drug programs. ow.ly/MXiz50R3CbA #HealthData #Pharma

We are testing a new approach that brings the societal perspective to our economic evaluations of certain new drugs.

Visit our website for details: cadth.ca/news/piloting-…

#HTA #HealthEconomics #CdnHealth

The Pan-Canadian Health Data Content Framework is now available for review until May 6. Your input will provide valuable insights as we modernize the flow of health information to help create a connected health system.

Learn more: ow.ly/cl1L50Rco19

Infoway Health Canada and PHAC

⚠️Call for Patient and Clinician Input⚠️ CADTH is requesting input on danicopan for paroxysmal nocturnal hemoglobinuria ( #PNH ).

Deadline is April 15, 2024: cadth.ca/danicopan #HTA

Choosing Wisely Canada’s 10th Anniversary National Meeting is just around the corner.

At the event, CADTH’s Elizabeth Carson and Tasha Narain will discuss the partnership between ChoosingWiselyCanada and CADTH regarding minimum retesting intervals for lab tests.